Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
EQS.PA

Price
35.35
Stock movement down
-0.55 (-1.53%)
Company name
Equasens S. A.
Exchange
(PA
,
Currency
EUR
)
Sector
Healthcare >
Health Information Services
Market cap
531.36M
Ent value
684.22M
Price/Sales
1.37
Price/Book
2.22
Div yield
-
Div growth
-
Growth years
-
FCF payout
11.59%
Trailing P/E
8.44
Forward P/E
11.64
PEG
-
EPS growth
4.77%
1 year return (CAGR)
-4.46%
3 year return (CAGR)
-23.12%
5 year return (CAGR)
-18.25%
10 year return (CAGR)
3.76%
Last updated: 2026-03-06

DIVIDENDS

EQS.PA does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E8.44
Price to OCF4.41
Price to FCF6.56
Price to EBITDA6.54
EV to EBITDA8.42

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.37
Price to Book2.22
EV to Sales1.77

FINANCIALS

Per share

Loading...
Per share data
Current share count15.03M
EPS (TTM)4.19
FCF per share (TTM)5.39

Income statement

Loading...
Income statement data
Revenue (TTM)386.79M
Gross profit (TTM)83.72M
Operating income (TTM)76.41M
Net income (TTM)62.92M
EPS (TTM)4.19
EPS (1y forward)3.04

Margins

Loading...
Margins data
Gross margin (TTM)21.65%
Operating margin (TTM)19.76%
Profit margin (TTM)16.27%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash18.79M
Net receivables62.13M
Total current assets162.34M
Goodwill103.95M
Intangible assets46.13M
Property, plant and equipment0.00
Total assets410.92M
Accounts payable17.50M
Short/Current long term debt49.13M
Total current liabilities125.42M
Total liabilities171.66M
Shareholder's equity239.27M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)120.37M
Capital expenditures (TTM)19.74M
Free cash flow (TTM)81.05M
Dividends paid (TTM)9.39M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity26.30%
Return on Assets15.31%
Return on Invested Capital24.21%
Cash Return on Invested Capital31.18%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open35.75
Daily high35.80
Daily low34.95
Daily Volume14K
All-time high122.60
1y analyst estimate56.74
Beta0.82
EPS (TTM)4.19
Dividend per share0.00
Ex-div date2 Jul 2025
Next earnings date30 Mar 2026

Downside potential

Loading...
Downside potential data
EQS.PAS&P500
Current price drop from All-time high-71.17%-1.82%
Highest price drop-73.37%-56.47%
Date of highest drop31 Mar 20259 Mar 2009
Avg drop from high-18.87%-10.84%
Avg time to new high27 days12 days
Max time to new high1410 days1805 days
COMPANY DETAILS
EQS.PA (Equasens S. A.) company logo
Marketcap
531.36M
Marketcap category
Small-cap
Description
Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare professionals and other tertiary sectors. It serves healthcare facilities and private healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme operates as a subsidiary of Marque Verte Sante.
Employees
1400
Investor relations
-
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Villers-lès-Nancy, 05 February 2026 - 6:00 PM (CET) PRESS RELEASE Strong commercial performance in 2025: Annual Recurring Revenue (ARR) of €108.0m (+8.8% as reported on 31 December 2025) and full-year...
February 5, 2026
EQUASENS ACCELERATES ITS DIGITAL TRAINING STRATEGY FOR HEALTHCARE PROFESSIONALS WITH THE ACQUISITION OF EREVO, A LEADING PURE-PLAY E-LEARNING PROVIDER Acquisition of a controlling 80% stake in Erevo, ...
January 5, 2026
Villers-lès-Nancy, December 10, 2026, 6:00 p.m. CET – Equasens (ISIN: FR 0012882389 – Ticker: EQS), a leader in digital solutions for healthcare professionals, announces its financial calendar for the...
December 10, 2025
Villers-lès-Nancy, 5 November 2025 - 6:00 PM (CET) PRESS RELEASE Revenue at 30 September 2025: €172.2m+8.9% on a reported basis and +7.3% like-for-like Group revenue at 09/30/2025 (€m)2024Reported bas...
November 5, 2025
As the European markets navigate a mixed landscape with the pan-European STOXX Europe 600 Index inching higher amidst dovish signals from the U.S. Federal Reserve and easing U.S.-China trade tensions,...
October 21, 2025
Villers-lès-Nancy, 26 September 2025 - 6:00 PM (CET) PRESS RELEASE 2025 half-year results Revenue: €116.0m (+7.4% reported and +6.4% like-for-like)Recurring EBITDA: €29.8m (+5.5%)Current Operating Pro...
September 26, 2025
Villers-lès-Nancy (France), 31 July 2025 - 6:00 PM (CET) PRESS RELEASE H1 revenue at 30 June 2025: €116.0m+7.4% on a reported basis and +6.4% like-for-like H1 2025 Group revenue (€m)2024Reported basis...
July 31, 2025
Villers-lès-Nancy (France), July 03, 2025 – 06 :00pm (CET) Press Release Equasens announces the departure of Damien VALICON, as Deputy Chief Executive Officer and Director of the Pharmagest Division H...
July 3, 2025
Villers-lès-Nancy, 1st July 2025 – 07:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 25 JUNE 2025 Number of shares compri...
July 1, 2025
Villers-lès-Nancy (France), 30 June 2025 - 06:00 PM (CET) PRESS RELEASE EQUASENS ACQUIRES DIS AND RESURGENCES BUSINESSES, STRENGTHENING ITS POSITION IN THE MARKET OF SOFTWARE SOLUTIONS FOR HEALTHCARE ...
June 30, 2025
Next page